Aims-To determine interleukin-IP (IL-1>) concentration in fetal and maternal plasma and amniotic fluid from pregnancies complicated by preterm prelabour amniorrhexis and to define the relation of this cytokine to intrauterine infection and the onset of labour. Methods-Cross-sectional study of 23 pregnancies complicated by preterm prelabour amniorrhexis. Enzyme linked immunoassay was used to measure IL-1p concentration in fetal and maternal plasma and amniotic fluid. In each case, fetal blood and amniotic fluid were cultured for micro-organisms. Results-In pregnancies with positive fetal blood and/or amniotic fluid cultures, plasma and amniotic fluid concentrations of IL-1p were higher and the interval between amniorrhexis and onset of labour was shorter than in the non-infected group. There were no significant associations between fetal plasma IL-1p and maternal plasma or amniotic fluid IL-1p concentrations, fetal leucocyte count or the interval between amniorrhexis and the onset of labour. Conclusions-These findings suggest that although intrauterine infection is associated with increased IL-1p concentrations in fetal plasma and amniotic fluid, there is no significant association between the concentration of IL-1p and the interval between amniorrhexis and the onset of labour. (J7 Clin Pathol 1995;48:368-371) 
Interleukin-1 (IL-1,B), which is produced by monocytes, macrophages, lymphocytes, and epithelial cells, has been implicated in the pathogenesis of preterm labour. Romero et al' reported that the concentration of IL-1,B in amniotic fluid was higher in pregnancies complicated by both microbial invasion of the amniotic cavity and preterm labour than in pregnancies with either preterm labour or microbial invasion of the amniotic cavity alone. In vitro studies have shown that both IL-1 and bacterial products stimulate prostaglandin release from the human amnion, 2 3and it was postulated that in the presence of infection there is release of cytokines which stimulate amniotic membranes to synthesise prostaglandins that induce uterine contractions.'45
The aim of this study was to determine whether, in pregnancies with preterm prelabour amniorrhexis, the concentration ofIL-1 ,B in fetal blood and amniotic fluid is related to the presence ofintrauterine infection and to the interval between membrane rupture and the onset of labour.
Methods IL-I P was measured in fetal blood from 23 pregnancies complicated by preterm prelabour amniorrhexis at 21-37 weeks ofgestation (mean 28 weeks) and the values were compared with those of 75 controls. The women with amniorrhexis were referred to our centre for amniocentesis and cordocentesis within three days of membrane rupture to establish the presence of intrauterine infection. The patients gave written informed consent to participate in the study which was approved by the Hospital Ethics Committee.
The diagnosis ofamniorrhexis was confirmed by the ultrasonographic demonstration of decreased or absent amniotic fluid and the visualisation of nitrazine positive fluid in the vagina. Cordocentesis and amniocentesis were performed using a single uterine transabdominal entry of a 20G needle under ultrasound guidance. In all cases umbilical venous blood was obtained and the Kleihauer-Betke test confirmed that all blood samples contained only fetal blood.
Fetal and maternal blood (obtained from the antecubital vein just before cordocentesis) were inoculated into aerobic and anaerobic blood culture bottles (Bactec, Becton-Dickinson, Sparks, Maryland, USA). The amniotic fluid was cultured using standard microbiological techniques and also inoculated into Mycofast liquid cultures for Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.: International Mycoplasma S.A., Toulon, France).
The patients were divided into three groups depending on the results of cultures. Group 1 included those patients with negative cultures of amniotic fluid and fetal blood. Group 2 consisted ofpatients who had positive amniotic fluid but negative fetal blood cultures. In group 3 the patients had positive fetal blood cultures.
In 18 cases the pregnancies were managed expectantly and the onset of labour was spontaneous. There were four inductions of labour, two each from groups 2 and 3 and one termination of pregnancy from group 3. The placentae were examined histologically for evidence of chorioamnionitis, which was defined by a polymorphonuclear leucocytic infiltration of the extraplacental membranes, the chorionic plate or umbilical cord blood vessels.
In the control group fetal blood samples were obtained either by fetal cardiocentesis from women undergoing elective terminations of pregnancy for social indications at 12-17 weeks of gestation (n = 22), by cordocentesis at 18-37 weeks from women undergoing prenatal diagnosis (n = 39) or by umbilical cord puncture at elective caesarean section at term for either breech presentation or previous caesarean section (n = 14). The indications for cordocentesis were fetal karyotyping because of advanced maternal age (n = 4), assessment of red blood cell isoimmunised pregnancies (n= 3) and karyotyping for fetal malformations, such as hydronephrosis, facial cleft or choroid plexus cysts (n = 32). In all cases the fetal abdominal circumference, haemoglobin concentration and leucocyte count were within the appropriate reference range for gestation and the fetal karyotype was normal. In all red blood cell isoimmunised pregnancies included in this study the fetuses were Coomb's negative.
Fetal blood samples (200 j.l) were used forfull blood count (Coulter S-Plus counter, Coulter Electronics, Luton, UK) and blood films to determine the leucocyte count. Fetal blood samples (400 ,ul) were also collected into 20 itl of isotonic edetic acid solution (0.5 mmol/l in 0.15 mmol/l sodium chloride) and centrifuged immediately at 0-4°C to avoid contamination with endotoxin and in vitro production of cytokine.6 The separated plasma was stored at -200C. The plasma IL-1 1 concentration was measured by enzyme linked immunoassay (Medgenix Diagnostics, Brussels, Belgium), which can detect minimal concentrations of 0 3 IU/ml. The intra-and interassay coefficients of variation were 3-4% and 4 4%, respectively.
In the amniorrhexis group the IL-13 concentration was also measured in maternal blood and amniotic fluid obtained at the time of amniocentesis and cordocentesis.
Regression analysis was used to determine whether the fetal blood IL-1 [ concentration in Median (range) for fetal plasma, amniotic fluid and maternal plasma IL-I1P concentrations, fetal and maternal leucocyte count and gestational age at preterm prelabour amniorrhexis (group 1, no infection; group 2, microbial invasion of the amniotic cavity; group 3, fetal bacteraemia). The time interval between amniorrhexis and delivery in the 18 pregnancies with spontaneous labour (eight in group 1, four in group 2, and six in group 3) was also recorded Group the control group was significantly associated with gestational age and leucocyte count. The rank analysis of variance test was used to examine the significance of differences in fetal plasma and amniotic fluid IL-1 3 concentrations between the amniorrhexis subgroups. In the amniorrhexis group regression analysis was used to determine the significance of associations between fetal blood and amniotic fluid IL-1 3 concentrations and the interval between membrane rupture and delivery in the 18 patients with spontaneous onset of labour.
Results
In the control group the gestation at fetal blood sampling was 12-38 (mean 24) weeks. There were no significant associations between the plasma IL-1 3 concentration and gestation (r=0 01, median 21i63IU/ml, range 0-01-48-16IU/ml) or fetal blood leucocyte count (r= -0 036). Of the patients with amniorrhexis 10 were in group 1, six in group 2 (five with positive amniotic fluid cultures ofM.h. and/or U.u. and one with Streptococcus agalactiae) and seven in group 3 (one case each with positive fetal blood cultures of Lactobacillus spp, Enterobacter spp, Stmeptococcus agalactiae, Streptococcus viridans, Streptococcus millen, Citrobacter spp, and Candida albicans).
In groups 2 and 3 fetal plasma and amniotic fluid IL-13 concentrations were significantly higher than values in group 1 and controls (table, figure) . Postpartum histological evidence for chorioamnionitis was present in all 13 cases in groups 2 and 3 and in one of the 10 cases in group 1. IL-13 concentrations were significantly higher in both fetal plasma (z=2 97, p<0 01) and amniotic fluid (z=2 01, p<0 05) in the cases with than in those without chorioamnionitis. The fetal plasma IL-13p concentration was not significantly associated with amniotic fluid IL-1p (r=0-348) or maternal plasma IL-13B (r = -0 1 39) concentrations, or the fetal leucocyte count (r =-0 -355).
In the 18 patients who underwent spontaneous labour, group 3 patients had a significantly shorter amniorrhexis to delivery interval than those in groups 1 and 2. However, there were no significant associations between fetal plasma or amniotic fluid IL-1 13 concentrations and amniorrhexis to delivery interval (n= 18, r= -0-423 and r= -0393, respectively).
Discussion
The results of this study demonstrate that in normal pregnancy IL-1 P is present in the fetal circulation from at least 12 weeks of gestation and the plasma concentrations are not related to the leucocyte count or the gestational age. In pregnancies with amniorrhexis and intrauterine infection fetal blood and amniotic fluid IL-13 concentrations are increased and the interval between amniorrhexis and delivery is reduced. However, there is no significant association between IL-1 13 concentrations and interval to delivery. IL-1 concentrations in plasma and amniotic fluid do not necessarily accurately reflect the amount produced or released into these compartments. Binding proteins such as IgG autoantibodies, oc2-macroglobulin and soluble receptors shed from cells following inflammatory episodes can influence the half-life of cytokines in the circulation and their distribution in other extracellular compartments. 6 Furthermore, cytokines usually act in synergy with or in opposition to other cytokines. In addition, a more complete picture of the biological role ofIL-1 in the infectious process necessitates measurement of IL-1,B receptor antagonists as well as of the agonist.6 Nevertheless, the main aim of this study was to compare circulating concentrations of IL-I13 in normal and a group ofpathological pregnancies rather than to quantify the production and biological activity of this cytokine.
In this study the diagnosis of intrauterine infection was based on the results of fetal blood and amniotic fluid cultures. Many authors have advocated the use of amniocentesis for the diagnosis ofintrauterine infection in cases ofpreterm prelabour amniorrhexis because the clinical signs of infection, such as maternal pyrexia or leucocytosis, are not specific and they develop late in the course of the disease. 101 However, in postnatal studies, the vast majority of infants with positive cultures of skin swabs or gastric aspirates (the equivalent of positive amniotic fluid cultures) are not infected and do not suffer any morbidity, unlike those who are shown to have bacteraemia." We assumed that the same may be true for the fetus, hence our protocol for the management of amniorrhexis includes culture of fetal blood.
There was an association between infection and increased fetal plasma and amniotic fluid IL- 13 concentrations. This is consistent with previous reports of increased concentrations of amniotic fluid IL-I13, other cytokines and prostaglandins in cases ofpositive amniotic fluid cultures and preterm labour.' '13" Chorioamnionitis may cause release of IL-i1 into both the fetal circulation and the amniotic fluid. In vitro studies have demonstrated release ofIL-11 by decidual and placental macrophages and syncytiotrophoblasts. 5 16 The lack of a significant association between fetal plasma and amniotic fluid IL-1 P concentrations does not preclude a common source of IL-1 1; findings in a cross-sectional study do not allow conclusions to be drawn on the dynamic inter-relation between two biological compartments. As the maternal plasma IL-13 concentration was not increased in the infected group, it is unlikely that transplacental transfer from the mother can explain the findings in fetal plasma and amniotic fluid. Although there was no significant association between fetal leucocyte counts and fetal plasma IL-11 concentrations, this does not exclude fetal leucocytes as the source of IL-113; in a previous study we demonstrated that fetal infection is associated with changes in lymphocyte subpopulations in the presence ofnormal leucocyte counts. 17 The association between infection and a shorter latency interval is compatible with the findings ofprevious studies, that in preterm prelabour amniorrhexis patients with chorioamnionitis deliver earlier than those without infection.'8 '9 The lack of a significant association between fetal plasma or amniotic fluid IL-1 P concentrations and the interval between amniorrhexis and onset of labour is in apparent contradiction with the hypothesis that there is a direct causal association between infection, cytokines, prostaglandins, and labour. It is acknowledged, however, that the lack of a statistical association does not rule out a role for cytokines in the initiation of labour. Gravett et al0 have demonstrated that in chronically instrumented pregnant rhesus monkeys intra-amniotic inoculation ofStreptococcus agalactiae was associated with an increase in IL-1 P and prostaglandin concentrations after 18 hours of inoculation and 10 hours before the onset of uterine contractions. As the relation between infection, cytokines and labour is a temporal one, it is not surprising that in our cross-sectional study it was not possible to demonstrate a significant association between the IL-I 1P concentration and the latency interval.
